Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1981 Jun;78(6):3930–3934. doi: 10.1073/pnas.78.6.3930

Somatostatin receptors: identification and characterization in rat brain membranes.

C B Srikant, Y C Patel
PMCID: PMC319687  PMID: 6115385

Abstract

We have identified and characterized specific receptors for tetradecapeptide somatostatin (SRIF; somatotropin release-inhibiting factor) in rat brain using [125I]Tyr11]SRIF as the radioligand. These receptors are present in membranes obtained from a subfraction of synaptosomes. Membranes derived from cerebral cortex bind SRIF with high affinity (Ka = 1.25 X 10(10) M-1) and have a maximum binding capacity (Bmax) of 0.155 X 10(-12) mol/mg. Neither opiates nor other neuropeptides appear to influence the binding of SRIF to brain membranes. Synthetic analogs with greater biological potency than SRIF--[D-Trp8]SRIF, [D-Cys14]SRIF, and [D-Trp8, D-Cys14]SRIF--bind to the receptors with greater avidity than SRIF, whereas inactive analogs [(2H)Ala3]SRIF and [Ala6]SRIF exhibit low binding. The ratio of receptor density to endogenous somatostatin is high in the cortex, thalamus, and striatum, low in the hypothalamus, and extremely low in the brain stem and cerebellum. Thus, SRIF receptors in the brain appear to be a distinct, new class of receptors with a regional distribution different from that of endogenous somatostatin.

Full text

PDF
3930

Images in this article

3932Image
on p.3932

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  2. Brownstein M., Arimura A., Sato H., Schally A. V., Kizer J. S. The regional distribution of somatostatin in the rat brain. Endocrinology. 1975 Jun;96(6):1456–1461. doi: 10.1210/endo-96-6-1456. [DOI] [PubMed] [Google Scholar]
  3. Burbach J. P., Loeber J. G., Verhoef J., de Kloet E. R., de Wied D. Biotransformation of endorphins by a synaptosomal plasma membrane preparation of rat brain and by human serum. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1296–1303. doi: 10.1016/0006-291x(79)90257-2. [DOI] [PubMed] [Google Scholar]
  4. Bylund D. B., Snyder S. H. Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol. 1976 Jul;12(4):568–580. [PubMed] [Google Scholar]
  5. Cotman C. W., Matthews D. A. Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. Biochim Biophys Acta. 1971 Dec 3;249(2):380–394. doi: 10.1016/0005-2736(71)90117-9. [DOI] [PubMed] [Google Scholar]
  6. Elde R., Hökfelt T., Johansson O., Schultzberg M., Efendić S., Luft R. Cellular localization of somatostatin. Metabolism. 1978 Sep;27(9 Suppl 1):1151–1159. doi: 10.1016/0026-0495(78)90034-3. [DOI] [PubMed] [Google Scholar]
  7. Epelbaum J., Brazeau P., Tsang D., Brawer J., Martin J. B. Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res. 1977 May 6;126(2):309–323. doi: 10.1016/0006-8993(77)90728-4. [DOI] [PubMed] [Google Scholar]
  8. Gfeller E., Kuhar M. J., Snyder S. H. Neurotransmitter-specific synaptosomes in rat corpus striatum: morphological variations. Proc Natl Acad Sci U S A. 1971 Jan;68(1):155–159. doi: 10.1073/pnas.68.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hirooka Y., Hollander C. S., Suzuki S., Ferdinand P., Juan S. I. Somatostatin inhibits release of thyrotropin releasing factor from organ cultures of rat hypothalamus. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4509–4513. doi: 10.1073/pnas.75.9.4509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirsch J. D., Grillo M., Margolis F. L. Ligand binding studies in the mouse olfactory bulb: identification and characterization of a L-[3H]carnosine binding site. Brain Res. 1978 Dec 15;158(2):407–422. doi: 10.1016/0006-8993(78)90684-4. [DOI] [PubMed] [Google Scholar]
  11. Iversen L. L., Snyder S. H. Synaptosomes: different populations storing catecholamines and gamma-aminobutyric acid in homogenates of rat brain. Nature. 1968 Nov 23;220(5169):796–798. doi: 10.1038/220796a0. [DOI] [PubMed] [Google Scholar]
  12. Kastin A. J., Coy D. H., Jacquet Y., Schally A. V., Plotnikoff N. P. CNS effects of somatostatin. Metabolism. 1978 Sep;27(9 Suppl 1):1247–1252. doi: 10.1016/0026-0495(78)90053-7. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Leitner J. W., Rifkin R. M., Maman A., Sussman K. E. Somatostatin binding to pituitary plasma membranes. Biochem Biophys Res Commun. 1979 Apr 13;87(3):919–927. doi: 10.1016/0006-291x(79)92045-x. [DOI] [PubMed] [Google Scholar]
  15. Marks N., Stern F., Benuck M. Correlation between biological potency and biodegradation of a somatostatin analogue. Nature. 1976 Jun 10;261(5560):511–512. doi: 10.1038/261511a0. [DOI] [PubMed] [Google Scholar]
  16. Marks N., Stern F. Inactivation of somatostatin (GH-RIH) and its an analogs by crude and partially purified rat brain extracts. FEBS Lett. 1975 Jul 15;55(1):220–224. doi: 10.1016/0014-5793(75)80996-3. [DOI] [PubMed] [Google Scholar]
  17. Meyers C., Arimura A., Gordin A., Fernandez-Durango R., Coy D. H., Schally A. V., Drouin J., Ferland L., Beaulieu M., Labrie F. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. Biochem Biophys Res Commun. 1977 Jan 24;74(2):630–636. doi: 10.1016/0006-291x(77)90349-7. [DOI] [PubMed] [Google Scholar]
  18. Moody T. W., Pert C. B., Rivier J., Brown M. R. Bomebesin: specific binding to rat brain membranes. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5372–5376. doi: 10.1073/pnas.75.11.5372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ogawa N., Thompson T., Friesen H. G., Martin J. B., Brazeau P. Properties of soluble somatostatin-binding protein. Biochem J. 1977 Aug 1;165(2):269–277. doi: 10.1042/bj1650269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Patel Y. C., Hoyte K., Martin J. B. Effect of anterior hypothalamic lesions on neurohypophysial and peripheral tissue concentrations of somatostatin in the rat. Endocrinology. 1979 Sep;105(3):712–715. doi: 10.1210/endo-105-3-712. [DOI] [PubMed] [Google Scholar]
  21. Patel Y. C., Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology. 1978 Feb;102(2):523–530. doi: 10.1210/endo-102-2-523. [DOI] [PubMed] [Google Scholar]
  22. Pert C. B., Snyder S. H. Opiate receptor: demonstration in nervous tissue. Science. 1973 Mar 9;179(4077):1011–1014. doi: 10.1126/science.179.4077.1011. [DOI] [PubMed] [Google Scholar]
  23. Reichlin S., Saperstein R., Jackson I. M., Boyd A. E., 3rd, Patel Y. Hypothalamic hormones. Annu Rev Physiol. 1976;38:389–424. doi: 10.1146/annurev.ph.38.030176.002133. [DOI] [PubMed] [Google Scholar]
  24. Renaud L. P., Martin J. B., Brazeau P. Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature. 1975 May 15;255(5505):233–235. doi: 10.1038/255233a0. [DOI] [PubMed] [Google Scholar]
  25. Rivier J., Brown M., Vale W. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun. 1975 Jul 22;65(2):746–751. doi: 10.1016/s0006-291x(75)80208-7. [DOI] [PubMed] [Google Scholar]
  26. Schonbrunn A., Tashjian A. H., Jr Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain. J Biol Chem. 1980 Jan 10;255(1):190–198. [PubMed] [Google Scholar]
  27. Schonbrunn A., Tashjian H., Jr Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem. 1978 Sep 25;253(18):6473–6483. [PubMed] [Google Scholar]
  28. Snodgrass S. R., Hedley-Whyte E. T., Lorenzo A. V. GABA transport by nerve ending fractions of cat brain. J Neurochem. 1973 Mar;20(3):771–782. doi: 10.1111/j.1471-4159.1973.tb00038.x. [DOI] [PubMed] [Google Scholar]
  29. Taylor D. P., Pert C. B. Vasoactive intestinal polypeptide: specific binding to rat brain membranes. Proc Natl Acad Sci U S A. 1979 Feb;76(2):660–664. doi: 10.1073/pnas.76.2.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Terenius L. Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors. Eur J Pharmacol. 1976 Jul;38(1):211–213. doi: 10.1016/0014-2999(76)90221-1. [DOI] [PubMed] [Google Scholar]
  31. Uhl G. R., Bennett J. P., Jr, Snyder S. H. Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes. Brain Res. 1977 Jul 15;130(2):299–313. doi: 10.1016/0006-8993(77)90277-3. [DOI] [PubMed] [Google Scholar]
  32. Vale W., Rivier J., Ling N., Brown M. Biologic and immunologic activities and applications of somatostatin analogs. Metabolism. 1978 Sep;27(9 Suppl 1):1391–1401. doi: 10.1016/0026-0495(78)90081-1. [DOI] [PubMed] [Google Scholar]
  33. Yamamura H. I., Snyder S. H. Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci U S A. 1974 May;71(5):1725–1729. doi: 10.1073/pnas.71.5.1725. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES